<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Triterpenoids were described in four halophytic grasses namely in 
 <italic class="italic">A. donax</italic> (from lipophilic extracts), 
 <italic class="italic">C. ciliaris</italic> (methanol, ethyl acetate, and hexane extracts), 
 <italic class="italic">C. dactylon</italic> (80% aqueous ethanol extract) and 
 <italic class="italic">I. cylindrica</italic> (chloroform/methanol extract) (
 <xref ref-type="app" rid="app1-ijms-20-01067" class="xref">Table S1</xref>). This subclass is well known for its pharmacological activities [
 <xref rid="B113-ijms-20-01067" ref-type="bibr" class="xref">113</xref>], for instance, α-amyrenone (
 <bold class="bold">168</bold>) and β-amyrenone (
 <bold class="bold">167</bold>), only reported in 
 <italic class="italic">A. donax</italic>, have the ability to interfere in acute and chronic inflammatory processes (oral administration, 23.5 μmol/kg) [
 <xref rid="B114-ijms-20-01067" ref-type="bibr" class="xref">114</xref>]. Ursolic acid (
 <bold class="bold">180</bold>), found only in 
 <italic class="italic">A. donax</italic>, possesses the ability to increase muscle mass and brown fat, leading to increased energy expenditure and therefore reduced obesity, improved glucose tolerance and decreased hepatic steatosis (high-fat diet supplemented with 0.14% ursolic acid, in rats) [
 <xref rid="B115-ijms-20-01067" ref-type="bibr" class="xref">115</xref>]. Lupeol (
 <bold class="bold">177</bold>), found only in 
 <italic class="italic">C. ciliaris</italic>, revealed topic anti-inflammatory activity in mouse’s ears (topical administration, 0.5 and 1 mg/ear dose) [
 <xref rid="B116-ijms-20-01067" ref-type="bibr" class="xref">116</xref>] and anticarcinogenic activity against T-lymphoblastic leukaemia CEM (IC
 <sub class="sub">50</sub>: 50 µM), breast carcinoma MCF-7 (IC
 <sub class="sub">50</sub>: 50 µM), lung carcinoma A-549 (IC
 <sub class="sub">50</sub>: 50 µM), multiple myeloma RPMI 8226 (IC
 <sub class="sub">50</sub>: 50 µM), cervical carcinoma HeLa (IC
 <sub class="sub">50</sub>: 37 µM) and malignant melanoma G361 (IC
 <sub class="sub">50</sub>: 50 µM) when treated for 72 h [
 <xref rid="B117-ijms-20-01067" ref-type="bibr" class="xref">117</xref>]. The mentioned biological capacities of lupeol were performed in vivo and in vitro [
 <xref rid="B118-ijms-20-01067" ref-type="bibr" class="xref">118</xref>] fact that, in our opinion, increases its significance.
</p>
